COVID ventilator infection study pulled before start
NCT ID NCT05256511
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to compare how often patients with severe COVID-19 developed lung infections while on a ventilator during the first and second waves of the pandemic. It was an observational study that would have looked back at patient records across European ICUs. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Started
-
Nov 2021
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with confirmed SARS-CoV-2 community-acquired pneumonia and receiving invasive mechanical ventilation for more than 48h in the participating ICUs from the start of COVID pandemic are eligible for this study.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Major (18 years and older) * Admitted to the ICU * Intubated and mechanically ventilated for more than 48 hours * With a confirmed community-acquired SARS-CoV2 pneumonia Exclusion Criteria: * Refusal to participate * Lack of social security coverage
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Severe COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hop Salengro - Hopital B Chr Lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.